[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fFLvzag_T-jic8hZX998pJ8H92bHpZloK6KGbj3moG-0":8,"$f5PT8oRoIUxdDKqZJKlFecQKx2cIwAyzuhctJEiir92M":54,"$f2h5UoUGykFq5BwThYRGdYqkqeufV9m1Z3-HwxMk8w7w":58},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":53},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":6,"postsTitle":18,"materialTotal":19,"videoTotal":20,"isConcern":7,"title":21,"coverVertical":22,"coverAcross":23,"content":24,"description":25,"views":26,"likes":20,"isThumbsUp":7,"isCollection":7,"collections":20,"createTime":27,"seoTitle":21,"seoKeywords":28,"seoDescription":29,"shelvesTime":30,"version":31,"menus":32,"menuId":34,"type":41,"quality":52,"commentCount":20,"isComment":41},66527,869630,[],"https://cdn.haohuanjiao.com/learnMaterial/ystApp//TThRKcLSiC1Hc4ArqPaQy8jEHpUCXXPW.png","郑宇","吉林大学第二医院","主治医师",22,0,"一文看懂弥漫大B淋巴瘤：你需要了解的关键知识","","https://ystcdn.venuertc.com/venue/AI/2e52f33f-00a5-4acd-861d-b9092991acee.jpg","\u003Cdiv class=\"dlbcl-material-guide\">\n  \u003Ch1 id=\"material_title\" class=\"dlbcl-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n    \u003Cspan class=\"dlbcl-icon\">🧬\u003C/span>一文看懂弥漫大B淋巴瘤：你需要了解的关键知识\n  \u003C/h1>\n\n  \u003Cdiv class=\"dlbcl-section\" style=\"background: linear-gradient(90deg, #f9fafc 60%, #e5eaf3 100%);\">\n    \u003Ch2 class=\"dlbcl-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n      01 弥漫大B淋巴瘤是什么？\n    \u003C/h2>\n    \u003Cdiv class=\"dlbcl-content\">\n      \u003Cp>如果身边有亲友突然说被查出了\"弥漫大B淋巴瘤\"（DLBCL），听上去名字有些拗口，不少人会感到一头雾水。简单来说，这是一种源自B淋巴细胞的血液恶性肿瘤，也就是淋巴系统里的特殊“防守队员”异常增生失控，变成了让身体头疼的“麻烦制造者”。\u003C/p>\n      \u003Cp>DLBCL并不罕见，是非霍奇金淋巴瘤中最常见的类型。它可以发生在任何年龄，不过更常出现在中老年群体，比如美国的统计数据显示，患者中有一半以上是60岁以上的人\u003Csup>[1]\u003C/sup>。不过，这种病虽然发展快，但不少早期病例经过及时规范治疗后是有治愈可能的。所以遇到这个词时，放心一点，及时就医和正规治疗很重要。\u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"dlbcl-section\" style=\"background: linear-gradient(90deg, #f8f9f2 60%, #dceae6 100%);\">\n    \u003Ch2 class=\"dlbcl-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n      02 弥漫大B淋巴瘤的主要症状有哪些？\u003Cspan class=\"dlbcl-emoji\">🔍\u003C/span>\n    \u003C/h2>\n    \u003Cdiv class=\"dlbcl-content\">\n      \u003Cul>\n        \u003Cli>\u003Cb>持续的淋巴结肿大：\u003C/b>有时脖子、腋下、腹股沟等部位能摸到慢慢变大的“疙瘩”，而且压上去不痛。\u003C/li>\n        \u003Cli>\u003Cb>夜间盗汗：\u003C/b>晚上出汗明显，常常需要更换睡衣。\u003C/li>\n        \u003Cli>\u003Cb>体重显著下降：\u003C/b>短时间内莫名其妙瘦掉5公斤甚至更多。\u003C/li>\n        \u003Cli>\u003Cb>反复发热：\u003C/b>不明原因的间断性或持续性发烧。\u003C/li>\n      \u003C/ul>\n      \u003Cp>有时一开始只是偶然摸到一个小结节，但如果后续肿块渐渐变大，或者合并了全身症状，比如盗汗、明显乏力，这时候就要格外警惕。\u003Cspan class=\"dlbcl-emoji\">⚠️\u003C/span>\u003C/p>\n      \u003Cp>举个例子：一位74岁的女士，最初只是皮肤上出现了无痛的结节，刚开始没有特殊不适。她的经历提醒我们，有些信号可能看似“无害”，但如果持续存在，比如结节没有消退、出现体重持续下降，就需要尽快到医院进行检查。\u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"dlbcl-section\" style=\"background: linear-gradient(90deg, #f9f6fa 60%, #e3e0ef 100%);\">\n    \u003Ch2 class=\"dlbcl-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n      03 弥漫大B淋巴瘤的潜在病因是什么？\u003Cspan class=\"dlbcl-emoji\">🧩\u003C/span>\n    \u003C/h2>\n    \u003Cdiv class=\"dlbcl-content\">\n      \u003Cp>说起来，DLBCL的发生并没有哪一种单一的原因，而是多种因素共同作用的结果。\u003C/p>\n      \u003Col>\n        \u003Cli>\n          \u003Cb>免疫系统异常\u003C/b>：有些人的免疫系统因为长期服用免疫抑制剂（如器官移植后的患者）、免疫系统疾病（如风湿性疾病）而功能减弱，B细胞就容易发生异常增殖\u003Csup>[2]\u003C/sup>。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>病毒感染\u003C/b>：像EB病毒（Epstein-Barr virus）这样的微生物，会让部分人的淋巴细胞受到反复刺激，增加恶变概率。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>遗传易感性\u003C/b>：一些家族性病例说明基因也可能“推波助澜”。不过，大多数患者是在没有家族史的情况下发病。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>年龄相关风险\u003C/b>：数据显示，DLBCL在老年人群体中更常见，可能与身体抵抗力下降以及细胞修复能力减弱有关。\n        \u003C/li>\n      \u003C/ol>\n      \u003Cp>其实，不是每个人都会因为这些因素就一定会得这个病，但如果拥有上述多个风险点，还是要多加小心。\u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"dlbcl-section\" style=\"background: linear-gradient(90deg, #f2fbfa 60%, #c5e3e2 100%);\">\n    \u003Ch2 class=\"dlbcl-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n      04 如何诊断弥漫大B淋巴瘤？\u003Cspan class=\"dlbcl-emoji\">🔬\u003C/span>\n    \u003C/h2>\n    \u003Cdiv class=\"dlbcl-content\">\n      \u003Cp>通常，医生会结合多个方面来判断：\u003C/p>\n      \u003Cul>\n        \u003Cli>\u003Cb>体格检查：\u003C/b>观察淋巴结肿大的部位、大小和质地。\u003C/li>\n        \u003Cli>\u003Cb>淋巴结活检：\u003C/b>将可疑的淋巴结组织取出一点，送到病理实验室，在显微镜下看细胞形态，这一步能明确诊断。\u003C/li>\n        \u003Cli>\u003Cb>影像学检查：\u003C/b>比如CT、PET等，通过扫描观察病灶分布，看看是否仅限于局部，还是全身多处都有。\u003C/li>\n        \u003Cli>\u003Cb>血液检查：\u003C/b>了解血液中细胞种类和数量、肝肾功能等，为了解身体的总体状况。\u003C/li>\n        \u003Cli>\u003Cb>分期和基因检测：\u003C/b>医生会根据以上检查，将疾病划分为I-IV期，并可能进一步检测肿瘤细胞相关基因，为后续治疗选择提供依据\u003Csup>[3]\u003C/sup>。\u003C/li>\n      \u003C/ul>\n      \u003Cp>正是这些“组合拳”，才让复杂的血液疾病得到准确定位。多数情况下，规范诊断能够大大减轻患者和家属的焦虑，让下一步治疗规划更清楚。\u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"dlbcl-section\" style=\"background: linear-gradient(90deg, #faf8f5 60%, #f5decf 100%);\">\n    \u003Ch2 class=\"dlbcl-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n      05 弥漫大B淋巴瘤的治疗方法及其效果如何？\u003Cspan class=\"dlbcl-emoji\">💊\u003C/span>\n    \u003C/h2>\n    \u003Cdiv class=\"dlbcl-content\">\n      \u003Cp>目前，DLBCL的治疗手段已经非常丰富。\u003C/p>\n      \u003Cul>\n        \u003Cli>\n          \u003Cb>化疗\u003C/b>：以R-CHOP方案（包含利妥昔单抗等几种药物）为主流，许多患者首次治疗后可获得良好缓解\u003Csup>[1]\u003C/sup>。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>放疗\u003C/b>：适合局部病变，常常与化疗联用。\u003C/li>\n        \u003Cli>\n          \u003Cb>靶向治疗/免疫治疗\u003C/b>：近年来，像CAR-T细胞疗法、单克隆抗体等新技术逐步进入现实应用，尤其对于复发或耐药的情况带来希望\u003Csup>[4]\u003C/sup>。\u003C/li>\n      \u003C/ul>\n      \u003Cp>不同患者、不同分期选择的组合方式可能不一样。有研究显示，早期病灶采用标准化疗，五年生存率可以较高，而晚期、复发或转化型病例，则需要更加多样化的策略（如造血干细胞移植等）。\u003C/p>\n      \u003Cp>前面提到的74岁女士，就曾接受了多种方案联合，包括单克隆抗体及化疗，病情曾获得缓解，但出现转化后又需要调整治疗模式。这提醒许多人，定期随访、关注身体变化是长期管理的关键。\u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"dlbcl-section\" style=\"background: linear-gradient(90deg, #f5faf4 60%, #e6eedc 100%);\">\n    \u003Ch2 class=\"dlbcl-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n      06 如何改善生活以应对弥漫大B淋巴瘤？\u003Cspan class=\"dlbcl-emoji\">🌱\u003C/span>\n    \u003C/h2>\n    \u003Cdiv class=\"dlbcl-content\">\n      \u003Cp>其实，合理的生活方式对病情管理和预后都有正向影响。\u003C/p>\n      \u003Cul>\n        \u003Cli>\u003Cb>均衡饮食：\u003C/b>多吃新鲜蔬果、瘦肉、豆制品，补充优质蛋白和维生素，利于身体修复。\u003C/li>\n        \u003Cli>\u003Cb>规律作息和温和锻炼：\u003C/b>像散步、轻体操，每天30分钟，有助于恢复体力、增强体质。\u003C/li>\n        \u003Cli>\u003Cb>保持心情舒畅：\u003C/b>适当聊天、阅读、轻松活动，有助于减轻治疗压力。\u003C/li>\n        \u003Cli>\u003Cb>定期随访、复查：\u003C/b>建议听从血液科医生建议，规律进行复查评估，及时掌握身体细微变化。\u003C/li>\n      \u003C/ul>\n      \u003Cp>比如日常饮食中，西兰花（含有丰富的抗氧化物）、鲑鱼（富含优质蛋白和Omega-3）、南瓜（提供多种矿物元素）都是不错的选择。具体可以参考“吃彩虹”：多种颜色的蔬菜交替搭配，每餐保证充足蛋白与维生素摄入。\u003Cbr>\n      预防疾病的最佳方式还是维护正常生活节奏，如果身体有不适，及时就医永远是最保险的做法。\u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"dlbcl-section\" style=\"background: linear-gradient(90deg, #f2f7fc 60%, #e5ecf4 100%);\">\n    \u003Ch2 class=\"dlbcl-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n      07 参考文献\n    \u003C/h2>\n    \u003Cdiv class=\"dlbcl-content\">\n      \u003Col>\n        \u003Cli>Armand, P. (2024). Diffuse Large B-Cell Lymphoma: What You Should Know. \u003Ci>Dana-Farber Cancer Institute Blog\u003C/i>. \u003Ca href=\"https://blog.dana-farber.org/insight/2024/04/diffuse-large-b-cell-lymphoma-what-you-should-know/\" target=\"_blank\">https://blog.dana-farber.org/insight/2024/04/diffuse-large-b-cell-lymphoma-what-you-should-know/\u003C/a>\u003C/li>\n        \u003Cli>Morton, L. M., Wang, S. S., Devesa, S. S., Hartge, P., Weisenburger, D. D., & Linet, M. S. (2006). Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. \u003Ci>Blood, 107\u003C/i>(1), 265–276. \u003Ca href=\"https://doi.org/10.1182/blood-2005-06-2508\" target=\"_blank\">https://doi.org/10.1182/blood-2005-06-2508\u003C/a>\u003C/li>\n        \u003Cli>Hans, C. P., Weisenburger, D. D., Greiner, T. C., Gascoyne, R. D., Delabie, J., Ott, G., ... & Jaffe, E. S. (2004). Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. \u003Ci>Blood, 103\u003C/i>(1), 275–282. \u003Ca href=\"https://doi.org/10.1182/blood-2003-05-1545\" target=\"_blank\">https://doi.org/10.1182/blood-2003-05-1545\u003C/a>\u003C/li>\n        \u003Cli>Neelapu, S. S., Locke, F. L., Bartlett, N. L., Lekakis, L. J., Miklos, D. B., Jacobson, C. A., ... & Siddiqi, T. (2017). Axicabtagene ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma. \u003Ci>The New England Journal of Medicine, 377\u003C/i>(26), 2531–2544. \u003Ca href=\"https://doi.org/10.1056/NEJMoa1707447\" target=\"_blank\">https://doi.org/10.1056/NEJMoa1707447\u003C/a>\u003C/li>\n      \u003C/ol>\n    \u003C/div>\n  \u003C/div>\n\u003C/div>\n\n\u003Cstyle>\n.dlbcl-material-guide {\n  font-family: \"Helvetica Neue\", Helvetica, Arial, sans-serif;\n  max-width: 820px;\n  margin: 24px auto 36px auto;\n  background: #fcfcfc;\n  border-radius: 16px;\n  box-shadow: 0 4px 28px 0 rgba(180,198,231,0.16);\n  padding: 36px 32px 28px 32px;\n  font-size: 18px;\n  color: #28394b;\n}\n\n.dlbcl-title {\n  font-weight: 800;\n  font-size: 2.2em;\n  letter-spacing: 0.04em;\n  text-align: center;\n  margin-bottom: 32px;\n  color: #344b68;\n  background: linear-gradient(88deg, #eae5f9 40%, #c5e3f8 100%);\n  padding: 28px 0 24px 0;\n  border-radius: 20px;\n  position: relative;\n  box-shadow: 0 2px 12px 0 rgba(180, 198, 231, 0.05);\n  line-height: 1.32;\n}\n\n.dlbcl-icon {\n  font-size: 1.2em;\n  margin-right: 10px;\n  vertical-align: middle;\n}\n\n.dlbcl-section {\n  margin-top: 36px;\n  margin-bottom: 20px;\n  border-radius: 16px;\n  padding: 28px 22px 14px 22px;\n  min-height: 140px;\n  box-shadow: 0 1px 8px 0 rgba(205, 215, 225, 0.06);\n  background-repeat: no-repeat;\n  background-position: top right;\n}\n\n.dlbcl-subtitle {\n  font-size: 1.44em;\n  font-weight: 700;\n  color: #497aaa;\n  margin-bottom: 14px;\n  display: flex;\n  align-items: center;\n}\n\n.dlbcl-emoji {\n  margin-left: 8px;\n  font-size: 1.1em;\n}\n\n.dlbcl-content {\n  font-size: 1em;\n  color: #344b65;\n  line-height: 1.9;\n}\n\n.dlbcl-section ul,\n.dlbcl-section ol {\n  padding-left: 22px;\n  margin-left: 0;\n  margin-bottom: 14px;\n}\n.dlbcl-section ul li,\n.dlbcl-section ol li {\n  margin-bottom: 10px;\n  line-height: 1.9;\n}\n\n.dlbcl-section b {\n  color: #4e8cc6;\n  font-weight: bold;\n}\n\n.dlbcl-section a {\n  color: #316b95;\n  text-decoration: underline;\n  word-break: break-all;\n}\n\n.dlbcl-section sup {\n  font-size: 0.88em;\n  color: #8ca7c7;\n  vertical-align: super;\n}\n\n@media (max-width: 600px) {\n  .dlbcl-material-guide {\n    padding: 10vw 2vw;\n    font-size: 15px;\n  }\n  .dlbcl-title {\n    font-size: 1.3em;\n    padding: 20px 0 12px 0;\n  }\n  .dlbcl-section {\n    padding: 15px 8px 6px 8px;\n    min-height: 80px;\n  }\n}\n\n\u003C/style>\n","\u003Cdiv class=\"dlbcl-material-guide\">\n  \u003Ch1 id=\"material_title\" class=\"dlbcl-title\" style=\"color: rgb(4",554,"2025-09-16 15:26:43","弥漫大B淋巴瘤, DLBCL, 淋巴系统, 症状, 治疗方法, 化疗, 靶向治疗, 病因, 免疫系统, 中老年人群, 体重下降","本文深入解读弥漫大B淋巴瘤（DLBCL）的症状、病因及治疗方法，提供权威知识助您及早识别，保持健康。针对中老年患者和其家庭人群，建议及时就医以提高治愈可能。","2025-11-04 07:02:41",2,[33],{"menuId":34,"menuName":35,"parentId":20,"orderNum":31,"path":36,"component":37,"isFrame":38,"isCache":39,"menuType":40,"visible":41,"status":20,"createDept":6,"remark":22,"createTime":42,"children":43,"columnImage":44,"columnLogo":45,"uncheckedLogo":6,"checkedLogo":6,"isHot":41,"isHome":20,"forceLogin":20,"color":46,"seoTitle":47,"seoKeywords":48,"seoDescription":49,"contentNum":6,"promotionalPoster":50,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":51,"routerPath":36,"componentInfo":37},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":55,"success":53},{"pageNo":41,"pageSize":56,"result":57,"totalSize":20},10,[],{"code":9,"msg":10,"message":6,"data":59,"success":53},{"authors":60,"appraiseDimensionScoresVos":61},[],[]]